MAP Cannabis Supply Health Canada Compliance: What Program Operators Need to Know
Last Updated: February 2026 | Reading Time: 5 minutes | Audience: Program directors, compliance leads, clinical operations
Managed Alcohol Programs that incorporate cannabis substitution operate at the intersection of two regulatory frameworks: the provincial and territorial requirements governing harm reduction programming, and the federal Cannabis Regulations (SOR/2018-144) governing the supply of cannabis to individuals. Understanding which framework governs which obligations — and where they sit — is the starting point for compliant program operation.
This article covers the federal cannabis supply requirements that apply specifically to MAP settings. For the broader MAP operational framework, the BCCSU/CISUR Managed Alcohol Programs: Canadian Operational Guidance (2023) remains the primary reference. For implementation guidance, see Adding Cannabis Substitution to a Managed Alcohol Program: An Operational Guide.
The Regulatory Starting Point: Who Holds Compliance Obligations
Under the Cannabis Regulations, cannabis can only be supplied to a patient by a federally licensed seller. The licensed seller — not the MAP, not the program operator, not the harm reduction organization — holds the compliance obligations under the Cannabis Act and its regulations.
This is the most important structural fact for MAP operators to understand. When a MAP participant is registered as a client of a licensed seller and that seller ships cannabis to the program address as a delivery location, the program’s regulatory exposure is narrow. The program does not purchase cannabis, does not hold a cannabis licence, and does not bear the inventory, security, or reporting obligations that apply to licensed sellers.
What the program does bear: responsibilities as the site where cannabis is received and distributed, which are governed by good practice and the terms of the registration, not by a specific federal cannabis licence requirement applied to the facility.
The Social Services Address Pathway
The mechanism that enables MAP supply is the social services address pathway under s.279 of the Cannabis Regulations. Under s.279(2)(b)(ii), a person who receives services from an organization that provides social services may register a program address as their shipping address with a licensed seller. Under s.279(4), the manager of the facility must sign a written declaration confirming that the facility provides social services to the registered individual.
The critical point: this pathway does not require the program to obtain any federal cannabis authorization. It requires a manager attestation – a brief declaration document – and maintains the licensed seller as the regulated party. The program’s role is limited to confirming the participant’s connection to the facility and receiving cannabis shipments on their behalf.
Flora’s registration and delivery model for participants in MAP and harm reduction settings has been developed in consultation with legal counsel and verified against the Cannabis Regulations. Contact our institutional team for the declaration documentation and onboarding process.
What Happens at the Program Site
Once cannabis is delivered to the program address for a registered participant, the program receives and distributes it. The Cannabis Regulations do not prescribe a specific storage or handling standard for program facilities operating under the social services pathway. The licensed seller’s obligations attach to the supply chain up to the point of delivery; the program’s obligations at that point are governed by the general duty of care and any applicable provincial or territorial requirements.
In practice, this means:
Storage: Cannabis should be stored separately from alcohol and other substances, in a secure location accessible only to authorized staff. A locked cabinet in a staff-only area is appropriate. The goal is to prevent diversion and maintain product integrity — not to meet the specific security standards that apply to licensed producers under Part 14, Division 3 of the Cannabis Regulations, which governs hospital settings and does not apply to harm reduction programs.
Distribution: Only registered participants should receive cannabis registered in their name. Dispensing logs tracking quantity distributed to each participant per session supports both program accountability and evaluation. If peer staff handle distribution, they should be trained on this record-keeping requirement.
Loss and theft: If cannabis registered to a participant is lost or stolen at the program site, notify the licensed seller promptly. The licensed seller holds the reporting obligation to Health Canada for losses from the licensed supply chain — but the program should maintain its own incident log and inform the seller to trigger their compliance process.
Disposal: Cannabis that cannot be distributed — because a participant has left the program, because the product has expired, or because of another reason — should be returned to the licensed seller. Programs do not have independent cannabis disposal authority.
Medical Authorization Requirements
Every participant registered with a licensed seller under this pathway must have a valid medical document — a written authorization from a licensed physician or nurse practitioner. The medical document specifies: the patient’s name, the healthcare practitioner’s information, the daily authorized quantity in grams, and a period of use up to one year.
The licensed seller verifies the medical document at the time of registration. The program’s role is to ensure participants have access to the clinical pathway needed to obtain one. For MAP populations who lack a family physician or whose existing practitioner is unwilling to authorize cannabis, this can be a meaningful access barrier.
Flora’s clinical team includes practitioners with direct experience providing medical authorizations in MAP and harm reduction contexts — the same practitioners whose clinical work is documented in the CMAPS research program. Programs working with Flora as their licensed seller can connect participants to clinical assessment as part of the onboarding process.
Authorization renewal is annual. Programs should track authorization expiry dates for enrolled participants and build renewal into the case management workflow so that lapses in authorization don’t interrupt supply.
What Changes If Your Program Is In a Hospital or Licensed Healthcare Facility
The framework above applies to harm reduction programs, shelters, supportive housing facilities, and day programs that operate as community organizations. If your program operates within a provincially licensed hospital or as part of a licensed healthcare facility, a different section of the Cannabis Regulations applies: Part 14, Division 3 (ss.330–353).
Under Division 3, hospitals that distribute cannabis operate under a distinct compliance structure. The security standard is “reasonable steps to protect from theft or loss” (s.347(a)). Loss and theft must be reported to the Minister within 10 days (ss.330, 342, 347). Records must be retained for a minimum of two years (s.351(2)). Distribution is capped at 30 times the daily authorized quantity or at 150 grams (s. 348(3)). Facilities cannot independently dispose of cannabis — they must return it to the licensed seller or transfer it for destruction (s.348(7)).
See Healthcare Cannabis Storage Protocols: Regulatory Requirements and Best Practices for the Division 3 framework in full.
If you are unsure which framework applies to your facility, that determination should be made by legal counsel familiar with your provincial licensing context.
Funder and Reporting Considerations
Programs funded through Health Canada’s Substance Use and Addictions Program (SUAP), provincial harm reduction grants, or municipal funding streams may be required to report on cannabis substitution as a program activity. The documentation requirements vary by funder.
The dispensing logs, intake records, and outcome-monitoring data your program generates through cannabis substitution – quantities dispensed, participant counts, sick cup data, if tracked, and adverse events — serve double duty as program evaluation data and funder reporting documentation. Building these into your standard operating procedures from the start avoids reconstruction later.
For programs that have or seek formal research partnerships, the same data infrastructure supports publication-quality evaluation. High Hopes Research Society and Flora Initiative have experience supporting MAP operators through both operational compliance and formal research evaluation processes.
Summary: Compliance Checklist for MAP Cannabis Substitution
Each enrolled participant has a valid medical document on file with the licensed seller, with expiry date tracked. Manager declarations completed under s.279(4) for all participants registered at the program address. Cannabis received and stored in a secured staff-only area, separate from alcohol. Dispensing log maintained for each participant. Lost or stolen cannabis reported to the licensed seller for Health Canada reporting. Expired or unclaimed cannabis returned to the licensed seller. Authorization renewals tracked and initiated before expiry. Participants in hospital or licensed healthcare facility settings assessed under Division 3 framework with legal counsel.
References
- Cannabis Regulations, SOR/2018-144, Part 14, Division 1 (ss.277–305) — client registration and medical documents
- Cannabis Regulations, SOR/2018-144, s.279 — social services address pathway
- Cannabis Regulations, SOR/2018-144, Part 14, Division 3 (ss.330–353) — hospitals and healthcare practitioners
- BCCSU and CISUR. (2023). Managed Alcohol Programs: Canadian Operational Guidance Document. Vancouver: BCCSU.
- Goulet-Stock, Hacksel, Scandiuzzi, Boyd, Pauly & Stockwell (2026). International Journal of Drug Policy, 147: 105083.
- Pauly, Brown, Chow, Wettlaufer, Graham, Urbanoski et al. (2021). Harm Reduction Journal, 18: 65.
This article is for informational purposes and does not constitute legal advice. Cannabis regulatory requirements are subject to change. Program operators should consult legal counsel for facility-specific compliance determinations. Flora Initiative’s compliance model has been developed in consultation with legal counsel and verified against the Cannabis Regulations.